300
Participants
Start Date
November 22, 2021
Primary Completion Date
November 30, 2025
Study Completion Date
July 31, 2026
Semaglutide
Glucagon-like Peptide 1 Receptor Agonist
RECRUITING
UTHealth Clinical Research Unit (CRU) at UT Brownsville, Brownsville
Vanderbilt University Medical Center
OTHER
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
NIH
The University of Texas Health Science Center, Houston
OTHER